Related references
Note: Only part of the references are listed.Gastric Emptying Impacts the Timing of Meal Glucose Peak in Subjects With Uncomplicated Type 1 Diabetes
Roberta Lupoli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Role of the endocannabinoid system in diabetes and diabetic complications
G. Gruden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The role of mast cells in functional GI disorders
Mira M. Wouters et al.
GUT (2016)
A Practical Approach to Gastrointestinal Complications of Diabetes
Abigail Maisey
DIABETES THERAPY (2016)
A Practical Approach to Gastrointestinal Complications of Diabetes
Abigail Maisey
DIABETES THERAPY (2016)
Endocannabinoids in the Gut
Nicholas V. DiPatrizio
CANNABIS AND CANNABINOID RESEARCH (2016)
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
M. Bashashati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Gastric Emptying Is More Rapid in Adolescents With Type 1 Diabetes and Impacts on Postprandial Glycemia
Shiree J. Perano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Hepatic insulin gene therapy prevents diabetic enteropathy in STZ-treated CD-1 mice
Shuo You et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2015)
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not higher
Y. Nasser et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Gastrointestinal complications of diabetes mellitus
Babu Krishnan et al.
WORLD JOURNAL OF DIABETES (2013)
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice
M. Bashashati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
Raquel Abalo et al.
PHARMACOLOGY (2012)
CB1 Cannabinoid Receptors and their Associated Proteins
Allyn C. Howlett et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice
M. A. Storr et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Intestinal and anorectal motility and functional disorders
Jutta Keller et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)
Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons
Munmun Chattopadhyay et al.
BRAIN (2009)
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
A. A. Izzo et al.
GUT (2008)
Targeting endocannabinoid degradation protects against experimental colitis in mice:: involvement of CB1 and CB2 receptors
Martin A. Storr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Role of motility in chronic diarrhoea
R. Spiller
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Gastrointestinal complications of diabetes mellitus
EC Ebert
DM DISEASE-A-MONTH (2005)
Involvement of cannabinoid receptors in gut motility and visceral perception
PJ Hornby et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cannabinoid receptors and their ligands
RG Pertwee et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
AA Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Prevalence of gastrointestinal symptoms associated with diabetes mellitus - A population-based survey of 15000 adults
P Bytzer et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Cannabinoids and the gastrointestinal tract
RG Pertwee
GUT (2001)
Relationships of upper gastrointestinal motor and sensory function with glycemic control
CK Rayner et al.
DIABETES CARE (2001)
Share Paper
